These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 32983165)

  • 1. Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance.
    Furumaya C; Martinez-Sanz P; Bouti P; Kuijpers TW; Matlung HL
    Front Immunol; 2020; 11():2100. PubMed ID: 32983165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune cells in the tumor microenvironment.
    Li MO; Wolf N; Raulet DH; Akkari L; Pittet MJ; Rodriguez PC; Kaplan RN; Munitz A; Zhang Z; Cheng S; Bhardwaj N
    Cancer Cell; 2021 Jun; 39(6):725-729. PubMed ID: 34129817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils in cancer.
    Treffers LW; Hiemstra IH; Kuijpers TW; van den Berg TK; Matlung HL
    Immunol Rev; 2016 Sep; 273(1):312-28. PubMed ID: 27558343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil: A New Player in Metastatic Cancers.
    Wu M; Ma M; Tan Z; Zheng H; Liu X
    Front Immunol; 2020; 11():565165. PubMed ID: 33101283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil diversity and plasticity in tumour progression and therapy.
    Jaillon S; Ponzetta A; Di Mitri D; Santoni A; Bonecchi R; Mantovani A
    Nat Rev Cancer; 2020 Sep; 20(9):485-503. PubMed ID: 32694624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils: important contributors to tumor progression and metastasis.
    Swierczak A; Mouchemore KA; Hamilton JA; Anderson RL
    Cancer Metastasis Rev; 2015 Dec; 34(4):735-51. PubMed ID: 26361774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.
    Groth C; Weber R; Lasser S; Özbay FG; Kurzay A; Petrova V; Altevogt P; Utikal J; Umansky V
    Int J Cancer; 2021 Nov; 149(9):1628-1638. PubMed ID: 34224592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
    Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D
    Front Immunol; 2018; 9():2250. PubMed ID: 30349530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis.
    Liang W; Ferrara N
    Cancer Immunol Res; 2016 Feb; 4(2):83-91. PubMed ID: 26839309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils: Critical components in experimental animal models of cancer.
    Hagerling C; Werb Z
    Semin Immunol; 2016 Apr; 28(2):197-204. PubMed ID: 26976824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
    Yoshida M; Taguchi A; Kawana K; Ogishima J; Adachi K; Kawata A; Nakamura H; Sato M; Fujimoto A; Inoue T; Tomio K; Mori M; Nagamatsu T; Arimoto T; Koga K; Hiraike OW; Oda K; Kiyono T; Osuga Y; Fujii T
    Int J Oncol; 2018 Oct; 53(4):1580-1590. PubMed ID: 30066851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.
    Singel KL; Segal BH
    Immunol Rev; 2016 Sep; 273(1):329-43. PubMed ID: 27558344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
    Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
    Front Immunol; 2020; 11():1395. PubMed ID: 32733461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy.
    Ginefra P; Lorusso G; Vannini N
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
    Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate myeloid cells in the tumor microenvironment.
    Duhan V; Smyth MJ
    Curr Opin Immunol; 2021 Apr; 69():18-28. PubMed ID: 33588308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
    Albini A; Bruno A; Noonan DM; Mortara L
    Front Immunol; 2018; 9():527. PubMed ID: 29675018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.